screening of anti-emetic drugs
TRANSCRIPT
SCREENING
ANTIEMETIC DRUGS
Dr. Prashant ShuklaJunior ResidentDept. of Pharmacology
INTRODUCTIONPATHOGENESIS OF VOMITINGCLASSIFICATION OF ANTI EMETIC DRUGSCHOICE OF ANIMALS AND EMETOGENSPARAMETERS OBSERVEDINVIVO MODELSINVITRO MODELSHUMAN MODELS
Contents
INTRODUCTIONNAUSEA: Non observable
subjective feeling of having an urge to vomit.
EMESIS ACUTE EMESIS (occurs within minutes
and resolves within 24 h) DELAYED EMESIS (occurs after 2-3 days) BREAKTHROUGH EMESIS (emesis
occurring after the prophylactic antiemetic treatment)
RETCHING: Attempt to vomit w/o expulsion of vomitus.
EJECTION: Expulsion of vomitus forcefully through mouth and nose.
DRUGS,RADIATION,METABOLIC PRODUCTS
MOTIONVESTIBULAR LABYRINTH
SENSORY STIMULICORTEX
LIMBIC SYSTEM
SYMPATHETIC & PARASYMPATHETIC
CEREBELLUM
VOMITING CENTRE IN NTS
CTZ IN AREA POSTREMA
BLOOD & CSF
VOMITING
PATHOGENESIS
CORTICAL AFFERENTS
VISCERAL AFFERENTS
CLASSIFICATION OF ANTIEMETICS
1. 5HT3 antagonists: ondansetron, tropisetron, palanosetron, granisetron
2. Centrally acting dopamine receptor antagonists: prochlorperazine, chlorpromazine
3. H1 receptor antagonists ex: Cyclizine, hydroxyzine, promethazine, diphenhydramine
4. Muscarinic antagonists ex:Scopolamine
5. Proinetic agents: Metoclopramide, Domperidone, Cisapride,Mosapride
6.Neurokinin receptor antagonists ex: Aprepitent
7. Cannabinoid receptor antagonists ex: Dronabinol, Nabilone
8. Corticosteroids and NSAIDs9. Benzodiazepines ex: Alprazolam, Diazepam
10. Phosphorated carbohydrate solutionsEx: Aqueous solutions of glucose,
fructose and phosphoric acid
CHOICE OF ANIMALSAnimals normally used-not useful
Degenerate vomiting reflex – rodents
Commonly used animals:Dogs House musk shrew (Suncus murinus)
Cats Least shrew (Cryptotis parva)Ferrets GerbilsMonkeys Pigeons
CHOICE OF EMETOGENSDRUG INDUCED RADIATION STIMULUSMOTION STIMULUS
PARAMETERS ASSESSEDBehavioral changesLatency to first retching and
vomitingNumber of vomiting episodesConditioned flavor avoidance
(PICA) in rats and mouse
DRUG INDUCED EMESIS MODELS
1. •Cisplatin- induced emesis model
2. •Apomorphine- induced emesis model
3. • CuSO4- induced emesis model
4. •Methotrexate- induced emesis model
Cisplatin-induced emesis model
Causes Both Acute And Delayed Emesis
Used as emetogen to evaluate acute emesis.
Solvent normal saline at 70oC followed by slow cooling to 40oC
Described by Gylys et al. Used to evaluate antiemetic properties of 5-
HT3 receptor antagonists.TEST GROUP: Test drug is administered.Ten mins later, cisplatin is administered IV at a dose of 3.2mg/kg/ml.
OBSERVATION FOR 5
HOURS
Dogs with no obvious
toxicity are retested after an
interval of 4 weeks.
CONTROL GROUP: Vehicle is administered.Ten mins later, cisplatin is administered IV at a dose of 3.2mg/kg/ml.
Cisplatin-induced dog model
Cisplatin-induced cat modelDescribed by John et al.
Cats of either sex, 2-6 kg.
TEST GROUP
Cisplatin is administered IV at a dose of 3- 7.5 mg/kg/ml over 4 m.
Immediately after this, Test drug is administered.
OBSERVATION FOR 4
HOURS FOR EMETIC EPISODES
CONTROL GROUP
Cisplatin is administered IV at a dose of 3- 7.5 mg/kg/ml over 4 m.
Immediately after this, Vehicle is administered.
Animals are subjected to overnight fasting.
Cisplatin-induced ferret model
TEST GROUP
Test drug and Cisplatin (IV at a dose of 10 mg/kg/ml) are administered.
If Test drug is given orally, give cisplatin 30 mins later.
OBSERVATION FOR 4
HOURS FOR EMETIC EPISODES
CONTROL GROUP
Vehicle and Cisplatin (IV at a dose of 10 mg/kg/ml) are administered.
Pigeon model
S. murinus model
Rat model
4 mg/kg IV 20 mg/kg IP 3-10 mg/kg IP
Duration between administration of drug/ vehicle and cisplatin depends upon expected time of drug action
Duration between administration of drug/ vehicle and cisplatin is 30 mins.
Cisplatin is administered 30 mins after rats have been pre-treated with drug/ vehicle.
Observed for emetic episodes
Observed for 2h for behavioral changes as well as emetic episodes (latency & frequency)
Observe for pica (ingestion of non-food substances)
Apomorphine- induced emesis model
Apomorphine is an opiate that acts as a potent central dopamine agonist directly at the area prostrema via dopamine receptors.
As the vestibular pathways are also involved in apomorphine-induced emesis, the active animals develop emesis readily than sedated and immobile animals.
Dogs most sensitive followed by ferret.
Use of apomorphine in cats is controversial as administration of apomorphine can cause excitation in cats.
Suncus murinus is unresponsive to apomorphine.
Dog model Ferret model Rat model
0.3 mg/kg SC 0.25 mg/kg SC 10 mg/kg IP
Duration between administration of drug and apomorphine depends upon expected time of drug action
Duration between administration of drug and apomorphine is 30 mins.
Apomorphine is administered to rats pre-treated with drug/ vehicle.
Observed for emetic episodes
Observed for 60 mins for behavioral changes as well as emetic episodes
Observe for pica (ingestion of non-food substances)
Copper sulfate-induced emesis modelCOPPER SULFATE (CuSO4)Powerful oxidizing agent and an irritant to mucosa membranes. If administered orally, it causes irritation of gastric mucosa and leads to nausea and vomiting.
Solvent: Distilled water
Dog model Cat model
100 mg/kg via an orogastric tube
40 mg/kg orally
Observed for 1 hour for emetic episodes
Cats are administered test drug/ vehicle followed by oral administration of threshold dose of CuSO4.
Dogs with no obvious toxicity are retested after an interval of 2 weeks.
Observed for emetic episodes
Ferret model Sun murinus model
Chick model
40 mg/kg orally 40 mg/kg intragastric
50 mg/kg orally
Drug/ vehicle pretreated ferrets are administered CuSO4.
Duration between administration of drug and CuSO4 is 30 mins.
Duration between administration of drug and CuSO4 is 10 mins.
Observed for latency and frequency of emetic episodes
Observed for 60 mins for emetic episodes
Observed for latency and frequency of emetic episodes
MTX- induced Delayed emesis modelAnimals: Dogs, cats, ferrets & shrews.MTX is prepared by dissolving in 5%
Dextrose.
Test drug/vehicle is administered at 24, 36, 48 &60 h after MTX.
Observed under video camera for 72h.
Animals can be retested with MTX at least 6 weeks later
Motion-induced emesis modelo Dogs are probably as sensitive to
motion-induced emesis as man.
COMMONLY USED MODELSo CAT MODELo SUNCUS MURINUS MODELo RAT MODEL
Cat model Suncus murinus model
Rat model
Vertical oscillations at 0.3 Hz through a distance of 75 cm
Horizontal oscillations of 4 cm at 1 Hz for 10 min
60 min double rotations
Repetitive licking, salivation often dripping out of mouth, or vomiting
Emetic episodes are noted during motion as well as after motion cease
↑ kaolin intake indicates motion sickness
↑ latency/ ↓frequency of emesis in cats pretreated with drug indicates antiemetic action
* Animal can be exposed only twice in 1 week d/t adaption to motion stimuli
↓ kaolin intake in rats pretreated with drug indicates antiemetic action
Radiation- induced emesis model
RADIATION INDUCED EMESIS MODEL
oDOG MODELoFERRET MODELoRAT MODEL
Ferrets are most sensitive to radiations followed by dogs. Cats are resistant to radiations.
Dog model Ferret model Rat model60Co; 8 Gy administered to total body surface
60Co; 201 cGy 4Gy of total body irradiation (abdominal > head irradiation)
One group gets drug & other group gets no medications
Emesis incidence of 100% is reported at 201 cGy in ferret
Exposure to radiation induces pica in rats
↑ latency/ ↓frequency of emesis in cats pretreated with drug indicates antiemetic action
↑ latency/ ↓frequency of emesis in cats pretreated with drug indicates antiemetic action
↓ kaolin intake in rats pretreated with drug indicates antiemetic action
Model for anticipatory nausea & vomiting
Anticipatory nausea and vomiting is described as conditioned response to cues present at the time of exposure to toxins as a result of pairing.
Often ass. with cancer chemotherapy.
S. murinus model
•Either sex, 20-50 g•Weaned at 20 days•Housed in transparent cages•Obs. Chamber well illuminated
LiCl 100 mg/kg IPVehicleObserved (45 min); 2nd /3rd conditioning trial
after 72 h, 144h
Test group
Control group
6 days later
LiCl 100 mg/kg IPVehicle
Test drug or vehicle is administered
Physiological saline is given Observe for emetic episodes
Rat model
4 conditioning trials (using LiCl) 72 hours apart
Drug/ vehicle is given to the rats
72 hours after 4th conditioning trial
0.1% saccharin sol. is delivered via surgically implanted cannulae every 5 min for 1 min (6inj in
30m)Rats are observed for gaping (equivalent to
emesis)
GAPING
In vitro modelsUsed to demonstrate the
pharmacological activity of newer anti-emetic agents.
5-HT3 # are the most potent of all anti-emetics.
The experimental drugs can be evaluated for 5-HT3 receptor antagonist activity using in vitro methods.
5-HT3 Receptor antagonists
1. Distal colon (20mm) of GP
2. Krebs-Henseleit solution
3. 2-methyl-5-HT (Agonist)
4. Tropisetron (Antagonist)
5. Temp: 37˚C6. Vol. (Inner bath) 10
mL7. pH: 7.3- 7.5
↑TROPISETRON
↑ ↑↑ conc./doses of 2-methyl-5-HT
No effect of 2-methyl-5-HT
Pict
oria
l Rep
rese
ntat
ion
Onl
y
Human ModelsApomorphine induced: Apomorphine, 0.05 mg/kg, SC is an appropriate
challenge dose for testing compounds for antiemetic activity in normal human volunteers.
Ipecac inducedHealthy men are given single 5-minute infusions
of ondansetron 30 minutes before oral administration of 30 ml syrup of ipecacuanha. Emetic episodes and nausea are assessed over an 8-hour period.
RECENT ADVANCES IN ANTI-EMETIC DRUGS
Drug name Class Indication
Approval year
Granisetron 5-HT3 #
CINV Aug 2016
Dronabinol oral sol.
CB-1 #, CB-2 #
CINV Jul 2016
Rolapitant NK-1# CINV Sep 2015Netupitant + Palonosetron
NK-1# + 5-HT3 #
CINV Oct 2014
Doxylamine succinate + Pyridoxine HCl DR
H1# Nausea and vomiting of pregnancy
Apr 2013
REFERENCESDrug screening methods by SK Gupta The Pharmacological Basis of Therapeutics
Goodman & Gilman- 12th edition. Basic and clinical Pharmacology Betram G
Katzung- 12 th Edition J Clin Pharmacol. 1978 Feb-Mar;18(2-3):95-9.An
apomorphine-induced vomiting model for antiemetic studies in man Proctor JD, Chremos AN, Evans EF, Wasserman AJ.
Clin Pharmacol Ther. 1993 Jul;54(1):53-7.Ipecacuanha-induced emesis: a human model for testing antiemetic drug activity.Minton N1, Swift R, Lawlor C, Mant T, Henry J.